Clinical trial
A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate…
NCT00196339 · Duramed Research, Industry · Completed
Key facts
| NCT number | NCT00196339 |
|---|---|
| Title | A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patients |
| Official title | A Dose-ranging Clinical Trial to Study the Efficacy and Safety of DR-2031 for the Treatment of Hot Flashes Following Surgical or Medical Castration of Prostate Cancer Patients |
| Lead sponsor | Duramed Research, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | Cyproterone acetate 5, Placebo, Cyproterone acetate 15, Cyproterone acetate 25 |
| Enrollment | 315 |
| Start date | Jun 1, 2005 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Sep 20, 2005 |
| Last update posted | Jul 22, 2016 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: